Marc Peters‐Golden

Medicine · University of Michigan

Established · publishing since 1978

Asthma and respiratory diseases Immune Response and Inflammation Inflammatory mediators and NSAID effects Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Eicosanoids and Hypertension Pharmacology

Publications

382

Citations

21,851

Est. group size

~30

Recurring co-author estimate

Active years

Publishing since 1978

In context

Among 4,953 established Medicine PIs within our index

Citations: 21,851cohort median 2,544

Publications / year (recent): 6.2cohort median 4.8

Typically publishes in teams of ~4 · 47% small-team papers (≤3 authors) · across 13 venues

Publication cadence

Publications per year over the last 10 years — averaging 6.2/year recently

Collaborators per year

Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.

Recent publications

Mechanistic basis for the antifibrotic actions of cAMP-based therapies
European Respiratory Review · 2026
Leukotrienes in Innate Immunity: Still Underappreciated after All These Years?
The Journal of Immunology · 2023
From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine · 2022
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
Frontiers in Pharmacology · 2022
Lipid Mediators: Overview
Elsevier eBooks · 2020
Lipid Mediators—Prostanoids
Elsevier eBooks · 2020
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation
Circulation · 2019
A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5‐lipoxygenase
Pulmonary Circulation · 2019
The Chemical Elucidation of Slow-Reacting Substance: Bronchospasm and Beyond
The Journal of Immunology · 2018
Leukotriene B<sub>4</sub>antagonism ameliorates experimental lymphedema
Science Translational Medicine · 2017
Alveolar Macrophages in Allergic Asthma: the Forgotten Cell Awakes
Current Allergy and Asthma Reports · 2017
The Induction of Pro–IL-1β by Lipopolysaccharide Requires Endogenous Prostaglandin E2 Production
The Journal of Immunology · 2017
Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs
Journal of Immunological Methods · 2017
Short-Term Regulation of Fc<i>γ</i>R-Mediated Phagocytosis by TLRs in Macrophages: Participation of 5-Lipoxygenase Products
Mediators of Inflammation · 2017
Simultaneously Targeting Myofibroblast Contractility and Extracellular Matrix Cross-Linking as a Therapeutic Concept in Airway Fibrosis
American Journal of Transplantation · 2016

Publishes in

The Journal of Immunology×6
bioRxiv (Cold Spring Harbor Laboratory)×4
The FASEB Journal×3
JCI Insight×3
American Journal of Physiology-Lung Cellular and Molecular Physiology×3

Similar researchers

By research-topic overlap

Sangwoon Chung
Medicine · The Ohio State University
Nicholas W. Lukacs
Medicine · University of Michigan
Xiangdong Wang
Medicine · University of Michigan
Matthew Wiest
Medicine · University of Michigan
B H Davies
Medicine · The Ohio State University

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 25, 2026.

Claim or correct this profile